Implementation of Seamless Phase I/II Design Proposed in
# A Seamless Phase I/II Platform Design with a Time-To-Event Efficacy Endpoint for Potential COVID-19 Therapies
# by
# T. Jaki, H. Barnett, A. Titman, and P. Mozgunov (2020)


The repository includes the following files:

# 1. AGILE_simulations_singleagent.R
Implementation of Phase I/II design with binary toxicity and time-to-event efficacy endpoint in a single-agent trial.

# 2. AGILE_simulations_combo.R
Implementation of Phase I/II design with binary toxicity and time-to-event efficacy endpoint in a dual-agent combination trial. 
